• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.54% Nasdaq Up0.27%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    414.51 Down 13.13(3.07%) 1:53PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Company EventsGet Company Events for:
    Upcoming Events 
    DateEvent
    Feb 9 - Feb 13, 2015 (Est.)Earnings announcement
    Recent Events 
    DateEvent
    26-Nov-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
    21-Nov-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
    4-Nov-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
    5-Aug-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
    18-Jun-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to
    23-May-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K/A, Unregistered Sale of Equity Securities
    19-May-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
    8-May-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
    9-Apr-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
    5-Mar-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
    13-Feb-14REGENERON PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
    11-Feb-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
    5-Feb-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
    16-Jan-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
    14-Jan-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
    13-Jan-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an